Dr. Robert James Postlewait, MD

Dr. Postlewait practices at South Austin Family Practice Clinic in Austin, Texas.

Dr. Postlewait's NPI, 1396907366, was assigned on June 30, 2008. Dr. Postlewait holds Oklahoma license 26505.

Dr. Postlewait's primary practice is South Austin Family Practice Clinic, at 5625 Eiger Rd, Austin, TX 78735 in Travis County. The practice phone is (512) 892-7076.

Dr. Postlewait's primary practice is South Austin Family Practice Clinic in Austin, Texas. Dr. Postlewait is also affiliated with St. David's Medical Center. The medical group on file is Ascension St. John. Dmand AI also links Dr. Postlewait to 1 more hospital, 4 medical groups, 1 group practice or clinic and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Postlewait practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Postlewait's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Postlewait is licensed in Oklahoma.

CMS data shows 875 Medicare services from Dr. Postlewait across 13 procedure codes in 2024, for 403 Medicare patients. Medicare paid $65,935 for them.

CMS counts 403 Medicare patients who saw Dr. Postlewait in 2024. The largest group is 75 to 84, with 140 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Postlewait's median patient age at 59, with 50% women.

In 2024, Dr. Postlewait wrote 712 Medicare Part D claims for 185 patients. 88% of them were for generic drugs. CMS names the drug for 362 of them, across 16 drugs with 11 or more claims each, at $12,751 in total drug cost. In 2023, CMS named 478 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Postlewait for performance year 2024, reported through an alternative payment model (APM). Dr. Postlewait accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Postlewait as offering telehealth.

CMS Open Payments shows 94 general payments to Dr. Postlewait from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $529.